Charles River Releases 2009 Research Models Products and Services US Catalog
| December 1, 2008 – For more than 60 years, the professional and technical staff at Charles River have made it our goal to understand and support the important role that research plays in improving human and animal health, because we know that every aspect of your research matters. As part of our commitment to providing high-quality animal models and services and to continuing to expand our products and services portfolio to meet your changing needs, we are pleased to announce the release of our 2009 Research Models Products and Services US catalog. Pricing listed in the catalog is effective January 1, 2009. |

Download the 2009 Research Models and Services US catalog |
Some of the unique benefits of partnering with Charles River, as well as some of our product and service enhancements for 2009, include:
- Access to the consulting services of our industry-leading Research Animal Diagnostic Services group. In addition to our existing services, our expanded testing portfolio includes new individual assays and PCR panels for refined screening of your rodent colonies. In September 2008, we opened our West Coast Laboratory in San Diego, Calif., to meet the need for local comprehensive animal health surveillance.
- The assurance that our continuously expanding portfolio of Research Models will be available to you when you need them. In 2008, we introduced the SCID Hairless Outbred (SHO™) mouse, an immunodeficient hairless model developed for use in oncology and tumor biology studies.
- The security of knowing that our expert Genetically Engineered Models and Services group can maintain your colonies to ensure they meet proper health standards. Our expanded portfolio this year offers you increased flexibility in deciding when and how often to cryopreserve germ plasm, expanded and more cost-effective options for housing large-scale rodent colonies, and enhanced embryology services that include Mouse Embryo Assay (MEA) testing and ES cell injection service.
- The confidence that our Discovery Services group can offer customized screening programs to ensure early and late lead candidate optimization. With our September 2008 acquisition of MIR Preclinical Services, we now offer expanded in vivo imaging and extensive oncology capabilities to complement our existing expertise in four key therapeutic areas – metabolic and cardiovascular disease, oncology, and inflammation.
We hope you will find our 2009 Research Models Products and Services catalog a useful resource. To request a hard copy of the US catalog, please complete the Ask Charles River form or call us at 1.877.CRIVER.1.